Medicinal Products

ALDALIX 50 mg / 20 mg

Generic drug of the therapeutic class: Cardiology and angiology
active ingredients: Spironolactone, Furosemide
laboratory: Pfizer Holding France

Box of 30
All forms


Congestive heart failure.

Dosage ALDALIX 50 mg / 20 mg Capsule Box of 30

1 to 2 capsules a day after the morning meal.

Against indications

- This medicine MUST NEVER BE USED in case of:
. hypersensitivity to spironolactone and sulfonamides;
. severe or acute renal failure;
. hyperkalemia;
. hepatic encephalopathy;
. hypovolemia or dehydration;
. hyponatremia;
. combinations with other potassium diuretics, with potassium salts (see section interactions).
- Due to the presence of lactose, this drug is contraindicated in case of congenital galactosemia, glucose-galactose malabsorption syndrome or lactase deficiency.
- This drug is generally not recommended in cirrhotic patients, when the serum is less than 125 mmol / L and in subjects who may have acidosis.
- Pregnancy: The administration of this product is not recommended during pregnancy. Diuretics may cause fetal-placental ischemia with a risk of fetal hypotrophy.
- Breast-feeding: Breast-feeding is not recommended because of excretion into breast milk.
- Associations discouraged : ciclosporin, tacrolimus; Angiotensin converting enzyme (ACE) inhibitors (unless there is hypokalemia) except for spironolactone at doses of 12.5 mg to 50 mg / day in the treatment of heart failure; angiotensin II receptor antagonists (unless there is hypokalemia); lithium.

Aldalix side effects

- Related to spironolactone :
. Gynecomastia may occur when using spironolactone; its development seems to be related to the dosage used and the duration of the therapy; it is usually reversible upon discontinuation of spironolactone but may persist in rare cases.
. Other side effects are rare and usually reversible when spironolactone is stopped: impotence in men, menstrual bleeding, digestive intolerances, rashes, somnolence, cramps of the lower limbs.
- Related to furosemide :
. Hydro-electrolytic disturbances can be observed: dehydration, hyperazotemia, hyponatremia, hypokalemia, hypovolemia, orthostatic hypotension. These disorders justify stopping treatment or reducing the dosage.
. In case of hepatocellular insufficiency, possibility of occurrence of hepatic encephalopathy (see contraindications).
. Few cases of skin reactions, sometimes bullous, lumbar pain, leukopenia and thrombocytopenia have been reported.
. Gastrointestinal disorders : anorexia, nausea, vomiting, abdominal pain or bloating, constipation and diarrhea. Manifestations related to diuresis (exceptional): dry mouth and thirst, paresthesia, vertigo, general weakness, fatigability, muscle cramps and orthostatic hypotension. An increase in serum uric acid may occur during treatment and exceptionally favor gout.

Popular Posts

Category Medicinal Products, Next Article